Glycomimetics INC
SEC CIK 1253689 · GLYC · last insider filing 2026-06-23
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Brumm Joshua T | Director · Chief Executive Officer | filed 2025 - 2026 |
| Lubner David Charles | Director | filed 2025 - 2026 |
| Harwin Peter Evan | Director | filed 2025 - 2026 |
| Violin Jonathan | Director | filed 2025 - 2026 |
| Fairmount Healthcare Fund II L.P. | Director | filed 2025 - 2026 |
| Fairmount Funds Management LLC | Director | filed 2025 - 2026 |
| Kiselak Tomas | Director | filed 2025 - 2026 |
| Moran Susan | Director | filed 2025 - 2026 |
| Balcom Alexandra | Director | filed 2025 - 2026 |
| Junius Daniel M | Director | filed 2016 - 2024 |
| Andrews Patricia S | Director | filed 2017 - 2024 |
| Pearson Timothy R | Director | filed 2014 - 2024 |
| Goldberg Mark Alan | Director | filed 2014 - 2024 |
| Jackson Scott Thomas | Director | filed 2018 - 2024 |
| Koenig Scott | Director | filed 2017 - 2024 |
| King Rachel K. | Director · President, CEO | filed 2014 - 2024 |
| Semerjian Harout | Director · Chief Executive Officer | filed 2021 - 2024 |
| Magnani John L. | Director · VP of Research, CSO | filed 2014 - 2022 |
| Barrett M James | Director | filed 2014 - 2018 |
| Baldwin John J. | Director | filed 2014 - 2016 |
| TOP Franklin H JR | Director | filed 2014 - 2016 |
| Henos Michael A | Director | filed 2014 - 2015 |
| Gust William M. | Director | filed 2014 - 2014 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lynch Ryan | See Remarks | filed 2025 - 2026 |
| Scalzo Richard William | Chief Financial Officer | filed 2025 - 2026 |
| Mcneill Jonathan | See Remarks | filed 2025 - 2026 |
| Im Ellie Eunkyung | Chief Medical Officer | filed 2025 - 2026 |
| Bispham Barbara Harlin | See Remarks | filed 2025 - 2026 |
| Pinkas Jan | Chief Scientific Officer | filed 2025 - 2026 |
| Doughty Christopher Grant | Chief Business Officer | filed 2025 - 2025 |
| Rock Edwin | Chief Medical Officer | filed 2022 - 2024 |
| Hahn Brian M. | SVP Finance, CFO | filed 2014 - 2024 |
| Rath Chinmaya | SVP and Chief Business Officer | filed 2023 - 2024 |
| Johnson Bruce S | SVP & Chief Commercial Officer | filed 2023 - 2024 |
| Girard Armand | SVP, Strategy & Corporate Dev | filed 2019 - 2022 |
| Feldman Eric Jay | Chief Medical Officer | filed 2021 - 2021 |
| Thackray Helen M. | VP Clinical Development, CMO | filed 2014 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.